E&C Democratic Leaders Urge FDA to Advance Clinical Trial Diversity Efforts
February 21, 2024
February 21, 2024
WASHINGTON, Feb. 21 -- Rep. Anna G. Eshoo, D-California, issued the following news release:
Energy and Commerce Committee Health Subcommittee Ranking Member Anna G. Eshoo (D-CA), Ranking Member Frank Pallone, Jr. (D-NJ), and Oversight and Investigations Subcommittee Ranking Member Kathy Castor (D-FL) wrote to Food and Drug Administration (FDA) Commissioner Robert M. Califf, M.D. to urge the agency to move forward with guidance to improve the diversity of populations represented in c . . .
Energy and Commerce Committee Health Subcommittee Ranking Member Anna G. Eshoo (D-CA), Ranking Member Frank Pallone, Jr. (D-NJ), and Oversight and Investigations Subcommittee Ranking Member Kathy Castor (D-FL) wrote to Food and Drug Administration (FDA) Commissioner Robert M. Califf, M.D. to urge the agency to move forward with guidance to improve the diversity of populations represented in c . . .